EVIDENCE & DEVELOPMENT
Building evidence begins with asking the right questions.
Anthogen is separating product capability, testing, plans, and evidence so that progress can be evaluated without turning development goals into public claims.
CLEAR CATEGORIES
Capability, testing, plans, and evidence are different things.
Capability
What the approved build can do now, demonstrated in a defined context.
Testing
What is being evaluated and may change before broader use.
Plans
Product direction that should not be read as a live feature or commitment.
Evidence
What a defined method and reviewed results support saying.
SAFETY AND USABILITY
Cardiac rehab is one of the best-supported interventions in cardiovascular care.
A Cochrane systematic review of exercise-based cardiac rehabilitation in coronary heart disease found that participation reduced cardiovascular mortality and hospital admissions compared with usual care.1 Subsequent reviews and the consensus statements that followed have continued to support cardiac rehabilitation as a Class I recommendation following acute myocardial infarction, percutaneous coronary intervention, and coronary artery bypass grafting.2
The 2024 update to the Core Components of Cardiac Rehabilitation Programs statement from the American Heart Association and the American Association of Cardiovascular and Pulmonary Rehabilitation reaffirms cardiac rehabilitation as central to secondary prevention, while acknowledging that program structure and delivery format must evolve to reach the patients who currently are not served.3
The clinical question, in 2026, is no longer whether cardiac rehab works. It is whether more eligible patients can be reached.
PATIENT ENGAGEMENT
Does the experience help with the daily work it is intended to support?
Relevant questions include comprehension, completion of intended actions, usefulness of reminders, confidence using the experience, and whether support feels respectful. These are engagement questions, not clinical-outcome claims.
PROVIDER WORKFLOW
Does useful information reach the right person without creating ambiguity?
Defined roles and review expectations
- Appropriate thresholds and escalation paths
- Useful information rather than noise
- Traceable changes to content and product behavior
CLINICAL AND REGULATORY DIRECTION
Boundaries must develop alongside capability.
Clinical review, intended use, claims, human oversight, documentation, and applicable regulatory questions must remain aligned as the product changes.
PRIVACY, SECURITY, AND RESPONSIBLE DATA
Collect and share only with a defined purpose.
Clear permission and information-use explanations
- Appropriate access and retention decisions
- Data rights and vendor responsibilities
- Security practices that are verified before they are described publicly
EVIDENCE PROCESS
Define the question before measuring the answer.
A disciplined process begins with the intended use, population, workflow, endpoint, method, ownership, and review plan. Results should be interpreted within those boundaries and published only after the necessary approvals.
CONTINUE THE CONVERSATION
Discuss evidence, development, or collaboration.
Contact Anthogen to discuss the product, clinical, workflow, privacy, security, and evidence questions shaping CardiFit.